Suppr超能文献

δ'-四氢大麻酚的口服活性及其对前列腺素E2的依赖性。

The oral activity of delta'-tetrahydrocannabinol and its dependence on prostaglandin E2.

作者信息

Fairbairn J W, Pickens J T

出版信息

Br J Pharmacol. 1979 Nov;67(3):379-85. doi: 10.1111/j.1476-5381.1979.tb08691.x.

Abstract

1 delta'-trans-Tetrahydrocannabinol (THC) is more active orally in mice than previously thought, as cataleptic responses occur at doses from 0.06 mg/kg upwards, with peak activity at 2 to 4 h after dosing. These doses and peaks correspond well with the effects in man. 2 Comparison with chlorpromazine in mice shows that chlorpromazine and THC are equipotent as cataleptics during the first 2 h after dosing; thereafter the THC activity increases to a peak when it is 5.67 times as active as chlorpromazine. 3 The cataleptic effect of THC is abolished by aspirin, indomethacine, diffunisal and phenylbutazone which inhibit the biosynthesis of prostaglandins and is restored by exogenous prostaglandin E2 (PGE2) but not PGE1 and PGF2 alpha. This suggests that the effect of THC depends upon the presence of PGE2. 4 In contrast, the cataleptic effect of chlorpromazine is not affected by pretreatment with aspirin. 5 THC is very much less active intraperitoneally than orally; our results suggest this is not due to poor absorption or extraction into fat depots. 6 Cannabidiol has no cataleptic effect.

摘要
  1. δ'-反式四氢大麻酚(THC)经口服对小鼠产生的作用比之前认为的更为显著,因为在剂量达到0.06毫克/千克及以上时会出现僵住反应,给药后2至4小时活性达到峰值。这些剂量和峰值与对人体产生的效果非常吻合。2. 在小鼠身上与氯丙嗪进行比较发现,给药后的前2小时内,氯丙嗪和THC作为僵住剂的效力相当;此后THC的活性增加至峰值,此时其活性是氯丙嗪的5.67倍。3. THC的僵住效应可被阿司匹林、吲哚美辛、二氟尼柳和保泰松消除,这些药物会抑制前列腺素的生物合成,且可通过外源性前列腺素E2(PGE2)恢复,但前列腺素E1和前列腺素F2α则无法恢复。这表明THC的作用取决于PGE2的存在。4. 相比之下,氯丙嗪的僵住效应不受阿司匹林预处理的影响。5. THC经腹腔注射的活性远低于口服;我们的研究结果表明,这并非由于吸收不良或在脂肪库中的摄取所致。6. 大麻二酚没有僵住效应。

相似文献

1
The oral activity of delta'-tetrahydrocannabinol and its dependence on prostaglandin E2.
Br J Pharmacol. 1979 Nov;67(3):379-85. doi: 10.1111/j.1476-5381.1979.tb08691.x.
2
Sedative activity of cannabis in relation to its delta'-trans-tetrahydrocannabinol and cannabidiol content.
Br J Pharmacol. 1981 Apr;72(4):649-56. doi: 10.1111/j.1476-5381.1981.tb09145.x.
3
4
Activity of cannabis in relation to its delta'-trans-tetrahydro-cannabinol content.
Br J Pharmacol. 1981 Mar;72(3):401-9. doi: 10.1111/j.1476-5381.1981.tb10990.x.
5
A major metabolite of delta 1-tetrahydrocannabinol reduces its cataleptic effect in mice.
Experientia. 1987 Apr 15;43(4):402-3. doi: 10.1007/BF01940427.
8
Interactions among the cannabinoids in the antagonism of the abdominal constriction response in the mouse.
Psychopharmacology (Berl). 1979 Mar 28;61(3):281-5. doi: 10.1007/BF00432273.
9
Interactions in man of delta-9-tetrahydrocannabinol. II. Cannabinol and cannabidiol.
Clin Pharmacol Ther. 1975 Jul;18(1):80-3. doi: 10.1002/cpt197518180.
10
delta-9-tetrahydrocannabinol (THC) increases brain prostaglandins in the rat.
Psychopharmacology (Berl). 1986;90(4):499-502. doi: 10.1007/BF00174068.

引用本文的文献

2
Cannabis-Induced Catatonia: A Case Series.
Cureus. 2020 Jun 13;12(6):e8603. doi: 10.7759/cureus.8603.
3
Preliminary Investigation of the Safety of Escalating Cannabinoid Doses in Healthy Dogs.
Front Vet Sci. 2020 Feb 11;7:51. doi: 10.3389/fvets.2020.00051. eCollection 2020.
4
Δ9-THC-caused synaptic and memory impairments are mediated through COX-2 signaling.
Cell. 2013 Nov 21;155(5):1154-1165. doi: 10.1016/j.cell.2013.10.042.
5
Alteration in the level of endogenous hypothalamic prostaglandins induced by delta 9-tetrahydrocannabinol in the rat.
Br J Pharmacol. 1982 May;76(1):115-9. doi: 10.1111/j.1476-5381.1982.tb09196.x.
6
Sedative activity of cannabis in relation to its delta'-trans-tetrahydrocannabinol and cannabidiol content.
Br J Pharmacol. 1981 Apr;72(4):649-56. doi: 10.1111/j.1476-5381.1981.tb09145.x.
7
Activity of cannabis in relation to its delta'-trans-tetrahydro-cannabinol content.
Br J Pharmacol. 1981 Mar;72(3):401-9. doi: 10.1111/j.1476-5381.1981.tb10990.x.
8
9
A major metabolite of delta 1-tetrahydrocannabinol reduces its cataleptic effect in mice.
Experientia. 1987 Apr 15;43(4):402-3. doi: 10.1007/BF01940427.
10
delta-9-tetrahydrocannabinol (THC) increases brain prostaglandins in the rat.
Psychopharmacology (Berl). 1986;90(4):499-502. doi: 10.1007/BF00174068.

本文引用的文献

1
Comparison of tetrahydrocannabinol and synhexyl in man.
Clin Pharmacol Ther. 1968 Nov-Dec;9(6):783-91. doi: 10.1002/cpt196896783.
4
Effects of (--)delta-9-trans-tetrahydrocannabinol in man.
Psychopharmacologia. 1967;11(2):184-8. doi: 10.1007/BF00401256.
5
Pharmacology of orally administered 9 -tetrahydrocannabinol.
Clin Pharmacol Ther. 1973 Jan-Feb;14(1):48-55. doi: 10.1002/cpt197314148.
6
The ring test: a quantitative method for assessing the 'cataleptic' effect of cannabis in mice.
Br J Pharmacol. 1972 Dec;46(4):753-63. doi: 10.1111/j.1476-5381.1972.tb06900.x.
7
Marihuana: importance of the route of administration.
J Pharm Pharmacol. 1971 Apr;23(4):309-10. doi: 10.1111/j.2042-7158.1971.tb08666.x.
10
The abdominal constriction response and its suppression by analgesic drugs in the mouse.
Br J Pharmacol Chemother. 1968 Feb;32(2):295-310. doi: 10.1111/j.1476-5381.1968.tb00973.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验